Hologic receives FDA warning letter over Biozorb implantable markers
Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.
Targeted Oncology3 小时
FDA Issues Complete Response Letter for Tab-cel in EBV+ PTLD
The FDA has issued a complete response letter to the biologics license application seeking the approval of tabelecleucel for ...
Future Market Insights11 小时
Medical Physics Industry to Surpass USD 10 Billion by 2034 with a 6.4% of CAGR
The global medical physics market is forecasted to grow from USD 5.3 billion in 2024 to USD 10 billion by 2034, at a CAGR of ...
Armed robbery in Revesby7 小时
Scorpius Takes Delivery of Four New Production Units
The first four line-replaceable units (LRUs), also referred to as pulsers, have been delivered to Lawrence Livermore National ...
Taiwan News22 小时
Global X-Ray Detector Market to Grow at 5.8% CAGR by 2030
The global X-ray detector market is expected to rise to register a compound annual growth of 5.8% in the forecast period 2022-2030. The growth witnessed by the market is attributed to increasing ...